SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689375-24-000027
Filing Date
2024-05-07
Accepted
2024-05-07 07:10:13
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20240331.htm   iXBRL 10-Q 1357666
2 EX-31.1 trda-20240331x10qex3111.htm EX-31.1 10862
3 EX-31.2 trda-20240331x10qex3121.htm EX-31.2 10885
4 EX-32.1 trda-20240331x10qex3211.htm EX-32.1 7213
  Complete submission text file 0001689375-24-000027.txt   5447401

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20240331.xsd EX-101.SCH 32737
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trda-20240331_cal.xml EX-101.CAL 57016
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20240331_def.xml EX-101.DEF 123591
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20240331_lab.xml EX-101.LAB 483636
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20240331_pre.xml EX-101.PRE 322367
71 EXTRACTED XBRL INSTANCE DOCUMENT trda-20240331_htm.xml XML 565219
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 24919581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)